We have investigated the mechanism underlying the modulation of the cardiac L-type Ca 2؉ current by protein kinase C (PKC). Using the patch-clamp technique, we found that PKC activation by 4-␣-phorbol 12-myristate 13-acetate (PMA) or rac-1-oleyl-2-acetylglycerol (OAG) caused a substantial reduction in Ba 2؉ current through Ca v1.2 channels composed of ␣11.2, ␤1b, and ␣2␦1 subunits expressed in tsA-201 cells. In contrast, Ba 2؉ current through a cloned brain isoform of the Ca v1.2 channel (rbC-II) was unaffected by PKC activation. Two potential sites of PKC phosphorylation are present at positions 27 and 31 in the cardiac form of Ca v1.2, but not in the brain form. Deletion of N-terminal residues 2-46 prevented PKC inhibition. Conversion of the threonines at positions 27 and 31 to alanine also abolished the PKC sensitivity of Ca v1.2. Mutant Cav1.2 channels in which the threonines were converted singly to alanines were also insensitive to PKC modulation, suggesting that phosphorylation of both residues is required for PKC-dependent modulation. Consistent with this, mutating each of the threonines individually to aspartate in separate mutants restored the PKC sensitivity of Ca v1.2, indicating that a change in net charge by phosphorylation of both sites is responsible for inhibition. Our results define the molecular basis for inhibition of cardiac Ca v1.2 channels by the PKC pathway.
C
alcium entering cardiac myocytes through voltage-gated L-type Ca 2ϩ channels underlies the plateau of the action potential and initiates contraction (1, 2) . L-type Ca 2ϩ current is dynamically regulated by second messenger-activated protein kinases, phosphatases, and G proteins (1) (2) (3) . Increased activity of L-type Ca 2ϩ channels due to activation of ␤-adrenergic receptors and phosphorylation by cAMP-dependent protein kinase contributes to the increase in beating rate and contractile force upon activation of the sympathetic nervous system (1) (2) (3) .
Molecular cloning studies have revealed that the Ca v 1.2 channels consisting of ␣ 1 1.2, ␤ 1 or ␤ 2 , and ␣ 2 ␦ subunits are responsible for L-type Ca 2ϩ currents in cardiac myocytes (4) (5) (6) (7) . The ␣ 1 subunit forms the voltage-gated, Ca 2ϩ -selective pore and is the target for calcium antagonist drugs, whereas the ␤ and ␣ 2 ␦ subunits modulate channel function and increase functional expression (5-7). The ␣ 1 1.2 subunit contains approximately 2,100 amino acids organized in four homologous domains with six transmembrane segments and a membrane-reentrant pore loop in each (5) (6) (7) . At each end of the protein are large intracellular N-terminal and C-terminal domains (5) (6) (7) .
Regulation of L-type Ca 2ϩ currents in cardiac and smooth muscle cells by receptor signaling pathways that activate protein kinase C (PKC) is well established. ␣-Adrenergic agonists (8) , intracellular ATP (9), extracellular ATP (10), glucocorticoids (11) , arginine-vasopressin (12) , pituitary adenylate cyclaseactivating polypeptide (13) , and angiotensin II (14) all regulate L-type Ca 2ϩ currents through the PKC pathway. In isolated cardiac myocytes, the effects of direct-acting PKC activators on the L-type Ca 2ϩ current are varied and depend on the experimental preparation under study. The response to PKC activation can be a decrease (15) (16) (17) or a biphasic change (increase followed by a decrease) in Ca 2ϩ current amplitude (18, 19) .
Expression of a single combination of Ca 2ϩ channel subunits in a heterologous cell type could in principle allow resolution of the distinct effects of PKC on Ca 2ϩ channel activity. However, when expressed in Xenopus oocytes, Ca v 1.2 channels typically respond to PKC activation with an initial increase in current followed by a decrease (20) (21) (22) (23) (24) (25) . In contrast, we find that Ca v 1.2 channels expressed in the tsA-201 cell line of human embryonic kidney cells are inhibited by PKC, as observed in some studies of cardiac myocytes (15) (16) (17) . Analysis of the molecular basis for this effect implicates phosphorylation of two threonine residues in the cardiac-specific N-terminal domain in inhibition of Ca v 1.2 channels by PKC.
Experimental Procedures
Construction of Mutants. cDNAs encoding the wild-type ␣ 1 1.2, ␤ 1b , and ␣ 2 ␦ subunits (5, (26) (27) (28) were subcloned into the pCDNA3.1 vector (Stratagene). The mutants were created by using overlap extension PCR mutagenesis with PFU Turbo (Stratagene). N-terminal PCR-generated mutagenic fragments of ␣ 1 1.2 were digested with HindIII and ClaI to enable a directional subcloning back into HindIII and ClaI predigested full-length ␣ 1 1.2 in pCDNA3.1. To delete amino acids 2 to 46, a mutagenic primer was designed that contains an internal HindIII restriction site and is composed of the 30 nucleotides flanking both sides of the nucleotides encoding amino acids 2 and 46 in ␣ 1 1.2. Mutations were confirmed by using automated cDNA sequencing (Applied Biosystems). DNA was prepared from transformed XL1-Blue competent Escherichia coli cells by using the Bio-Rad MaxiPrep Kit, following the manufacturer's recommended protocols.
Cell Culture. tsA-201 cells, a subclone of the human embryonic kidney cell line HEK-293 that expresses the simian virus 40 T antigen (a gift of Robert Dubridge, Cell Genesis, Foster City, CA), were grown in DMEM͞Ham's F-12 medium (Life Technologies, Grand Island, NY), supplemented with 10% (vol͞vol) FBS (HyClone), and incubated at 37°C in 10% CO 2 .
Expression. tsA-201 cells were grown to 90% confluence, suspended with trypsin͞EDTA, and plated onto 35-mm culture dishes (Corning) at 40% confluence 24 h before transfection. Immediately before transfection, the medium was replaced with fresh DMEM͞F-12 supplemented with serum and antibiotics, and the cells were transiently transfected with cDNAs encoding rabbit cardiac ␣ 1 1.2 (5) or rat brain ␣ 1 1.2 (26), ␤ 1b (27) , and ␣ 2 ␦ 1 (28) subunits at a 1:1:1 molar ratio by using the calcium phosphate technique as described (29) . In addition, cells were Abbreviations: PKC, protein kinase C; PMA, 4-␣-phorbol 12-myristate 13-acetate; OAG, rac-1-oleyl-2-acetylglycerol.
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Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073͞pnas.210384297. Article and publication date are at www.pnas.org͞cgi͞doi͞10.1073͞pnas.210384297 cotransfected at a 10-fold lower molar concentration with a CD-8 antigen (EBO-pCD-Leu2; American Type Culture Collection). The cells were incubated overnight at 37°C in 3% CO 2 . After 16 h, the medium was replaced with fresh DMEM͞F-12, and the cells were allowed to recover for 9-12 h. After recovering from transfection the cells were suspended by using EDTA, plated in 35-mm dishes, and incubated at 37°C in 10% CO 2 for 1-2 days before recordings. Patch pipettes were fabricated from VWR micropipettes and fire-polished. They had typical resistances of 2 M⍀ in the solutions used in this study. After seal formation, the membrane beneath the pipette was ruptured and the pipette solution was allowed to dialyze into the cell for 1-2 min before recording. Currents were elicited by depolarization from a holding potential of Ϫ80 mV to various test potentials for 50-100 ms with an interpulse interval of 10 to 30 s. Voltage-dependent currents have been corrected for leak by using an on-line P͞4 subtraction paradigm. Data were recorded at 10 kHz and filtered at 2 kHz before being stored directly on the computer hard drive. 4-␣-Phorbol 12-myristate 13-acetate (PMA) and rac-1-oleyl-2-acetylglycerol (OAG) were prepared as 1 mM and 20 mM stock solutions, respectively, in DMSO and frozen in aliquots at Ϫ20°C. Immediately before use, a dilution of the required drug stock was prepared in extracellular recording solution such that the concentration of DMSO never exceeded 0.1%. At this concentration, there was no effect of DMSO on the Ca v 1.2 channel current. Data analysis was performed by using IGOR PRO Version 3.12 (WaveMetrics, Lake Oswego, OR), and graphs were prepared by using ORIGIN currents through the resulting L-type Ca 2ϩ channels were decreased by activation of PKC with PMA (100 nM) (Fig. 1A) . No transient increase in Ba 2ϩ current was observed preceding the decrease. In contrast to these results with the cardiac Ca v 1.2 channel, an isoform of Ca v 1.2 cloned from rat brain (rbC-II; ref. 26 ) was unaffected by activation of PKC with PMA ( Fig. 1 A, open circles) , as reported previously for expression of this isoform in Xenopus oocytes (30) . These results suggest that the cardiac isoform of Ca v 1.2 is specifically sensitive to regulation by PKC.
To test the specificity of the effects of PMA, we also activated PKC with OAG (20 M). Activation with this diacylglycerol analog also inhibited Ba 2ϩ current (Fig. 1B) . The peak Ba 2ϩ current was decreased without a shift in the voltage dependence of activation ( Fig. 2 A and B) . Peak Ba 2ϩ current was reduced 61.5 Ϯ 7.1% by PMA (n ϭ 6) and 63.9 Ϯ 8.7% by OAG (n ϭ 5; Fig. 2C ). The decrease in the Ba 2ϩ current was not reversed by wash-out of the PKC activator during typical experiments of 8 to 15 min. The effects of PMA (100 nM) on the Ca v 1.2 channel current required PKC phosphorylation because the PKC inhibitor peptide PKC-I(19 -36) blocked its effects (n ϭ 2).
Effect of Mutations in the N-Terminal Domain on Regulation by PKC.
We focused initially on the proximal N-terminal domain as the site of PKC regulation of the channel because the rat brain Ca v 1.2 channel isoform rbC-II (26), which lacks a segment within the first 46 amino acid residues in N-terminal domain of the rabbit cardiac isoform (see sequences below), is insensitive to PKC activators (30) . Two potential PKC phosphorylation sites containing a threonine followed at the ϩ2 or ϩ3 positions by one or more positively charged residues are found in this segment (bold shaded residues in sequences).
cDNA encoding a mutant Ca v 1.2 channel that lacked amino acid residues 2 to 46 in the N-terminal domain was constructed. This mutant formed functional Ca v 1.2 channels when expressed in tsA-201 cells, but truncation of the N terminus abolished the sensitivity to PMA (Fig. 3A) . On average, the effect of PMA was reduced from a 61.5 Ϯ 7.1% decrease in Ba 2ϩ current to a 2.9 Ϯ 1.8% decrease. This N-terminal segment contains two possible PKC phosphorylation sites, at threonine-27 and threonine-31. To determine whether these threonine residues are required for the PKC effects, a mutant (TTAA) was generated in which both threonines were mutated to alanine residues. The loss of the two threonines made the channel insensitive to PKC activators, suggesting that phosphorylation at these sites is required for inhibition of Ca v 1.2 channels by PKC (Fig. 3B ).
Both Threonine-27 and Threonine-31 Are Required for PKC Regulation.
To examine the role of these two threonine residues separately, two further mutants were generated in which each of the threonines was mutated individually to alanine, and the resulting Ca v 1.2 channels were tested for sensitivity to PKC activators. Surprisingly, when either threonine-27 or threonine-31 was mutated to an alanine (T27A and T31A, respectively), the resulting single T 3 A mutant was insensitive to modulation by PKC activators (Fig. 3B ). These data indicated that both threonines must be available for phosphorylation for PKC to inhibit the Ca v 1.2 channel.
Negative Charge at Positions 27 and 31 Supports Inhibition of Cav1.2.
Phosphorylation of a neutral amino acid residue introduces negative charge at that site. We tested whether phosphorylation of either threonine could be mimicked by mutation to a negatively charged aspartate residue. When either threonine 27 or threonine 31 was converted to aspartate, the Ba 2ϩ current remained sensitive to modulation by PKC, presumably by phosphorylation of the remaining site (Fig. 4) . These data indicate that the net gain of negative charge at positions 27 and 31 within the N terminus region is a prerequisite for PKC-dependent modulation of the L-type Ca 2ϩ channel. These results support a 
Modulation of L-type Ca 2ϩ
currents by PKC has been reported to result in a transient increase followed by a decrease, or a decrease in Ca 2ϩ channel activity in isolated cardiac myocytes and smooth muscle cells (see Introduction). In this study, the response of the cardiac Ca v 1.2 channel to PKC activation in tsA-201 cells was consistently a progressive loss of Ba 2ϩ current without any transient increase, consistent with results in some of the previous studies of cardiac myocytes (15) (16) (17) . In our experiments, Ba 2ϩ was used as the permeant ion, and intracellular Ca 2ϩ transients were buffered by 10 mM EGTA. Because Ba 2ϩ does not support PKC activity in purified enzyme preparations from rat brain (31, 32) , the inhibitory effect of PKC activation on Ca v 1.2 channels is likely to be caused by activation of PKC by phorbol esters and OAG without an accompanying Ca 2ϩ transient under our experimental conditions. Consistent with our results, allowing changes in the intracellular Ca 2ϩ concentration by lowering the intracellular EGTA from 10 mM to 1 mM did not alter the response of the Ca 2ϩ channel to PKC activators in cardiac myocytes (33) .
The reasons for the different responses of Ca v 1.2 channels to PKC activation observed in different studies are unknown. One possible explanation is differential activation or membrane translocation of PKC isozymes in various cell preparations under the experimental conditions used in the different studies. PKC isozymes may phosphorylate different sites on the Ca v 1.2 channel, resulting in opposing functional effects. In adult rat cardiac myocytes, peptides corresponding to the C2 region of PKC abolished the PMA-induced decrease in Ca 2ϩ current (17) . Of the 11 cloned isoforms of PKC, only ␣ I , ␤ I , and ␤ II have a C2 domain, so one of these isoforms is most likely responsible for the inhibitory effects of PKC on the Ca 2ϩ current in this cell type. In the brain, species and age-related changes in PKC translocation have been suggested to arise as a result of differences in PKC anchoring (34) . Thus, a combination of differential activation and translocation of PKC isozymes in different cell types and under different experimental conditions may lead to opposing effects on Ca v 1.2 channel activity. Isolation of the inhibitory effect of PKC under our experimental conditions in tsA-201 cells has allowed us to analyze the molecular basis for this form of regulation of Ca v 1.2 channel activity by PKC. Development of experimental conditions to isolate the activating effect of PKC will be necessary to analyze its molecular mechanism and to determine the relative importance of these opposing effects on channel activity in cardiac myocytes under different experimental conditions. Both threonines must be available for phosphorylation, as mutation of either to an alanine rendered the channel insensitive to modulation by PKC. In addition, mutant channels in which either of these threonines was mutated singly to aspartate retained sensitivity to modulation by activators of PKC. Although we have not directly measured phosphorylation of these threonine residues, these results suggest that the local increase in negative charge in the N terminus of the channel after PKC phosphorylation is responsible for the inhibitory effect of PKC. If this region of the Ca v 1.2 channel is ␣-helical, these two threonine residues would be located close to each other in adjacent turns of the helix and would be presented together for phosphorylation and for interactions with other parts of the channel protein.
In contrast to our results, studies of a comparable cardiac Ca v 1.2 channel expressed in Xenopus oocytes showed biphasic regulation (24, 25) . Mutants with a truncated N terminus lost sensitivity to regulation by PKC activators (25) . However, a purified fusion protein containing residues 1-46 of Ca v 1.2, which contained the two threonines critical for the inhibitory effect of PKC on the Ca v 1.2 channel in our experiments in tsA-201 cells, was not phosphorylated in vitro. We assume that differences in the PKC isozymes in Xenopus oocytes and tsA-201 cells are responsible for these differences in regulatory effects. -binding motif and a calmodulin-binding region are involved in Ca 2ϩ -dependent inactivation (35) (36) (37) (38) . A serine at position 1928 is an important site for phosphorylation by cAMPdependent protein kinase (PKA) and consequent increase in Ca v 1.2 activity (39, 40) . In vivo proteolytic processing truncates the C terminus and removes serine 1928 (39, 41, 42) , and truncation of the C terminus increases Ca v 1.2 activity when expressed in Xenopus oocytes (43, 44) . The function of the N terminus has been less well characterized. Similar to the C terminus, truncation greatly enhances the probability of channel opening in Xenopus oocytes and in HEK-293 cells (24, 45) . Our results presented here show that phosphorylation of threonine residues in the N-terminal domain by PKC can inhibit channel activity. It is possible that the increase in Ca v 1.2 channel activity after truncation of the N-terminal domain reflects, in part, prevention of tonic inhibition by PKC phosphorylation. The N-terminal and C-terminal domains of Ca 2ϩ channels are thought to interact in the folded structure of the protein. Therefore, these two structural components of the channel may form an extended regulatory domain that responds to changes in Ca 2ϩ , protein phosphorylation by both the PKA and PKC pathways, and regulated proteolysis. Integration of these different regulatory signals may provide sensitive modulation of channel activity in response to diverse patterns of cellular stimulation by hormones, neurotransmitters, and electrical activity.
